Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 472

Results For "LA"

8560 News Found

Health Ministry and Defence Ministry ink MoU to set up dedicated Tele MANAS cell for armed forces
Policy | June 06, 2024

Health Ministry and Defence Ministry ink MoU to set up dedicated Tele MANAS cell for armed forces

The special Tele MANAS cell to serve as a dedicated mental health assistance helpline for all Armed Forces beneficiaries across country


Jemperli trial continues to show positive results for deficient (dMMR) rectal cancer
Clinical Trials | June 06, 2024

Jemperli trial continues to show positive results for deficient (dMMR) rectal cancer

Updated analysis from Memorial Sloan Kettering Cancer Center presented at ASCO 2024 has expanded to 42 patients with clinical complete response


Shilpa Biologicals files Type IV DMF of recombinant Human Albumin 20% with USFDA
Drug Approval | June 06, 2024

Shilpa Biologicals files Type IV DMF of recombinant Human Albumin 20% with USFDA

This novel recombinant has been developed and is a patented novel recombinant Human Albumin 20% process


Bayer and Samsung take action against sleep disturbances associated with menopause
News | June 06, 2024

Bayer and Samsung take action against sleep disturbances associated with menopause

Sleep disturbances are among the most frequent and disruptive symptoms associated with menopause which can impact women’s health and quality of life


Melissa Seymour to join Lilly as executive vice president of Global Quality
People | June 06, 2024

Melissa Seymour to join Lilly as executive vice president of Global Quality

Seymour is recognized as one of the foremost quality leaders in the pharmaceutical industry


Melissa Seymour to join Lilly as executive vice president of Global Quality
People | June 06, 2024

Melissa Seymour to join Lilly as executive vice president of Global Quality

Seymour is recognized as one of the foremost quality leaders in the pharmaceutical industry


AstraZeneca’s Tagrisso plus chemo recommended for approval in EU
Drug Approval | June 05, 2024

AstraZeneca’s Tagrisso plus chemo recommended for approval in EU

Recommendation based on FLAURA2 results which showed Tagrisso plus chemotherapy extended median progression-free survival by nearly 9 months


Moderna & Merck announce 3-year data for mRNA-4157 in combination with Keytruda
Clinical Trials | June 05, 2024

Moderna & Merck announce 3-year data for mRNA-4157 in combination with Keytruda

The companies have initiated Phase 3 studies in patients with high-risk melanoma and non-small cell lung cancer


AstraZeneca completes acquisition of Fusion Pharmaceuticals
News | June 05, 2024

AstraZeneca completes acquisition of Fusion Pharmaceuticals

This acquisition complements AstraZeneca’s leading oncology portfolio with the addition of the Fusion pipeline of RCs


Aurigene Pharmaceutical opens biologics facility in Genome Valley, Hyderabad
News | June 04, 2024

Aurigene Pharmaceutical opens biologics facility in Genome Valley, Hyderabad

The state-of-the-art facility is equipped with best-in-class equipment and control systems